Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Eptinezumab for Pediatric Migraine
Recruiting2 awardsPhase 3
Grand Rapids, Michigan
This trial will investigate the safety of eptinezumab in children and adolescents with chronic or episodic migraines.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service